biote Corp
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
BTMD$1.08-2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(in thousands, except share and per share amounts) (Unaudited)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenue: | ||||
| Product revenue | $49,806 | $44,831 | $143,952 | $137,638 |
| Service revenue | 1,578 | 726 | 3,405 | 2,019 |
| Total revenue | 51,384 | 45,557 | 147,357 | 139,657 |
| Cost of revenue | ||||
| Cost of products | 14,431 | 13,070 | 41,659 | 41,089 |
| Cost of services | 741 | 1,097 | 2,167 | 2,783 |
| Cost of revenue | 15,172 | 14,167 | 43,826 | 43,872 |
| Selling, general and administrative | 24,028 | 23,791 | 74,687 | 72,636 |
| Income from operations | 12,184 | 7,599 | 28,844 | 23,149 |
| Other income (expense), net: | ||||
| Interest expense, net | (3,542) | (1,530) | (7,779) | (4,821) |
| Loss from change in fair value of warrant liability | — | — | — | (13,411) |
| Gain (loss) from change in fair value of earnout liabilities | 7,213 | 17,450 | (18,825) | (14,360) |
| Other income (expense) | — | (3) | (4) | (14) |
| Total other income (expense), net | 3,671 | 15,917 | (26,608) | (32,606) |
| Income (loss) before provision for income taxes | 15,855 | 23,516 | 2,236 | (9,457) |
| Income tax expense | 3,198 | 3,874 | 5,673 | 5,426 |
| Net Income (loss) | 12,657 | 19,642 | (3,437) | (14,883) |
| Less: Net income (loss) attributable to noncontrolling interest | 1,955 | 12,112 | (2,891) | (10,465) |
| Net income (loss) attributable to biote Corp. stockholders | $10,702 | $7,530 | $(546) | $(4,418) |
| Other comprehensive income (loss): | ||||
| Foreign currency translation adjustments | (8) | 8 | (10) | 8 |
| Other comprehensive income (loss) | (8) | 8 | (10) | 8 |
| Comprehensive income (loss) | $12,649 | $19,650 | $(3,447) | $(14,875) |
| Net income (loss) per common share | ||||
| Basic | $0.34 | $0.25 | $(0.02) | $(0.19) |
| Diluted | $0.33 | $0.24 | $(0.02) | $(0.19) |
| Weighted average common shares outstanding | ||||
| Basic | 31,045,174 | 30,334,193 | 33,235,662 | 22,921,401 |
| Diluted | 32,260,809 | 31,041,245 | 33,235,662 | 22,921,401 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.